Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Cancer Metastasis Rev. 2018 Mar;37(1):107–124. doi: 10.1007/s10555-017-9717-6

Fig 1.

Fig 1

The destiny of synthetic siRNA-loaded nanoparticles with desirable structural and functional properties. (A) Components of ideally designed nanoparticles for RNAi delivery; (B) Process of RNAi; (C) Clinical application of siRNA-based drugs.